https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14491 Wed 11 Apr 2018 16:17:33 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14512 120 g/L) and iron-sufficient young women (18–35 years). Cognitive function and haematological markers of iron status were measured at baseline and follow-up. Iron-deficient participants (n = 24) were randomised to receive placebo, 60 mg or 80 mg elemental iron daily supplements for 16 weeks. A control group of iron-sufficient participants (n = 8) was allocated to placebo. Change scores for Impulsivity and Attention were significantly greater in plasma ferritin improvers than in non-improvers (p = 0.004, p = 0.026). IntegNeuro was easy to administer and acceptable to young women. Based on the differences in Memory and Attention scores between iron-deficient participants on iron treatment and those on placebo, it was decided that between 26 and 84 participants would be required in each iron treatment group for an adequately powered extension of this pilot RCT.]]> Wed 11 Apr 2018 10:25:27 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14504 Sat 24 Mar 2018 08:21:41 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14518 Sat 24 Mar 2018 08:19:46 AEDT ]]>